[20 alpha-Dihydropregnenolone-sulfate and 20 alpha-dihydroprogesterone biosynthesis and metabolism in feto-placental unit]. 1984

Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama

To study the biosynthesis of 20 alpha-dihydropregnenolone-sulfate (20P5-S) and 20 alpha-dihydroprogesterone (20P4) in the feto-placental unit, human fetal liver and placenta were incubated with various radioactive precursors which included 14C-pregnenolone (P5), 14C-progesterone (P4), 14C-20 alpha-dihydropregnenolone (20P5) and 14C-20P5-S. In fetal liver, it was found that sulfokinase and 20 alpha-hydroxysteroid dehydrogenase (20HSD) activities were localized in 105,000xg supernatant obtained by a conventional differential centrifugation method. As cofactors, sulfokinase and 20HSD require ATP and NADPH, respectively. When P5 was incubated for varying periods with 105,000xg supernatant of liver homogenate, the precursor decreased with incubation time, whereas labeled 20P5-S increased steadily. A rapid increase in the 20P5 followed by declining amounts with further incubation occurred, suggesting a possible role of 20P5 as intermediates in 20P5-S formation from P5. When 20P-S was used as a precursor in the incubation with placental homogenate for different periods of time, rapid conversion to P4 was observed with a bell-shaped curve depicting 20P5 and 20P4 whereas the recovery of P5 remained low throughout the incubation period. These in vitro results indicate that the placental P4 and 20P4 might be synthesized, in part, from 20P5-S which is derived from fetal liver during pregnancy.

UI MeSH Term Description Entries
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008431 Maternal-Fetal Exchange Exchange of substances between the maternal blood and the fetal blood at the PLACENTA via PLACENTAL CIRCULATION. The placental barrier excludes microbial or viral transmission. Transplacental Exposure,Exchange, Maternal-Fetal,Exposure, Transplacental,Maternal Fetal Exchange
D009249 NADP Nicotinamide adenine dinucleotide phosphate. A coenzyme composed of ribosylnicotinamide 5'-phosphate (NMN) coupled by pyrophosphate linkage to the 5'-phosphate adenosine 2',5'-bisphosphate. It serves as an electron carrier in a number of reactions, being alternately oxidized (NADP+) and reduced (NADPH). (Dorland, 27th ed) Coenzyme II,Nicotinamide-Adenine Dinucleotide Phosphate,Triphosphopyridine Nucleotide,NADPH,Dinucleotide Phosphate, Nicotinamide-Adenine,Nicotinamide Adenine Dinucleotide Phosphate,Nucleotide, Triphosphopyridine,Phosphate, Nicotinamide-Adenine Dinucleotide
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011284 Pregnenolone A 21-carbon steroid, derived from CHOLESTEROL and found in steroid hormone-producing tissues. Pregnenolone is the precursor to GONADAL STEROID HORMONES and the adrenal CORTICOSTEROIDS. 5-Pregnen-3-beta-ol-20-one,5 Pregnen 3 beta ol 20 one
D011374 Progesterone The major progestational steroid that is secreted primarily by the CORPUS LUTEUM and the PLACENTA. Progesterone acts on the UTERUS, the MAMMARY GLANDS and the BRAIN. It is required in EMBRYO IMPLANTATION; PREGNANCY maintenance, and the development of mammary tissue for MILK production. Progesterone, converted from PREGNENOLONE, also serves as an intermediate in the biosynthesis of GONADAL STEROID HORMONES and adrenal CORTICOSTEROIDS. Pregnenedione,Progesterone, (13 alpha,17 alpha)-(+-)-Isomer,Progesterone, (17 alpha)-Isomer,Progesterone, (9 beta,10 alpha)-Isomer
D004092 20-alpha-Dihydroprogesterone A biologically active 20-alpha-reduced metabolite of PROGESTERONE. It is converted from progesterone to 20-alpha-hydroxypregn-4-en-3-one by the 20-ALPHA-HYDROXYSTEROID DEHYDROGENASE in the CORPUS LUTEUM and the PLACENTA. Dihydroprogesterone,20 alpha-Dihydroprogesterone,20 alpha-Hydroxy-4-Pregnen-3-One,20 alpha-Hydroxyprogesterone,20-alpha-Hydroxyprogesterone,20alpha-Hydroxypregn-4-Ene-3-One,Pregn-4-en-3-one, 20-alpha-hydroxy-,20 alpha Dihydroprogesterone,20 alpha Hydroxy 4 Pregnen 3 One,20 alpha Hydroxyprogesterone,20-alpha-hydroxy- Pregn-4-en-3-one,20alpha Hydroxypregn 4 Ene 3 One,Pregn 4 en 3 one, 20 alpha hydroxy
D005260 Female Females
D005333 Fetus The unborn young of a viviparous mammal, in the postembryonic period, after the major structures have been outlined. In humans, the unborn young from the end of the eighth week after CONCEPTION until BIRTH, as distinguished from the earlier EMBRYO, MAMMALIAN. Fetal Structures,Fetal Tissue,Fetuses,Mummified Fetus,Retained Fetus,Fetal Structure,Fetal Tissues,Fetus, Mummified,Fetus, Retained,Structure, Fetal,Structures, Fetal,Tissue, Fetal,Tissues, Fetal

Related Publications

Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
July 1987, Nihon Sanka Fujinka Gakkai zasshi,
Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
December 1999, Biological & pharmaceutical bulletin,
Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
September 1965, Rivista di anatomia patologica e di oncologia,
Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
December 1998, Clinics in perinatology,
Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
March 1991, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.),
Y Sanai, and T Suzuki, and T Yanaihara, and T Nakayama
November 1975, Acta endocrinologica,
Copied contents to your clipboard!